<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mustali M Dohadwala</style></author><author><style face="normal" font="default" size="100%">Monika Holbrook</style></author><author><style face="normal" font="default" size="100%">Naomi M Hamburg</style></author><author><style face="normal" font="default" size="100%">Sherene M Shenouda</style></author><author><style face="normal" font="default" size="100%">William B Chung</style></author><author><style face="normal" font="default" size="100%">Megan Titas</style></author><author><style face="normal" font="default" size="100%">Matthew A Kluge</style></author><author><style face="normal" font="default" size="100%">Na Wang</style></author><author><style face="normal" font="default" size="100%">Joseph Palmisano</style></author><author><style face="normal" font="default" size="100%">Paul E Milbury</style></author><author><style face="normal" font="default" size="100%">Jeffrey B Blumberg</style></author><author><style face="normal" font="default" size="100%">Joseph A Vita</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effects of cranberry juice consumption on vascular function in patients with coronary artery disease</style></title><secondary-title><style face="normal" font="default" size="100%">The American Journal of Clinical Nutrition</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/21411615</style></url></web-urls></urls><number><style face="normal" font="default" size="100%">5</style></number><volume><style face="normal" font="default" size="100%">93</style></volume><pages><style face="normal" font="default" size="100%">934–940</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">{{{\textless}AbstractText} {Label=&quot;BACKGROUND&quot;} {NlmCategory=&quot;BACKGROUND&quot;{\textgreater}Cranberry} juice contains polyphenolic compounds that could improve endothelial function and reduce cardiovascular disease {risk.{\textless}/AbstractText{\textgreater}} {{\textless}AbstractText} {Label=&quot;OBJECTIVE&quot;} {NlmCategory=&quot;OBJECTIVE&quot;{\textgreater}The} objective was to examine the effects of cranberry juice on vascular function in subjects with coronary artery {disease.{\textless}/AbstractText{\textgreater}} {{\textless}AbstractText} {Label=&quot;DESIGN&quot;} {NlmCategory=&quot;METHODS&quot;{\textgreater}We} completed an acute pilot study with no placebo (n = 15) and a chronic placebo-controlled crossover study (n = 44) that examined the effects of cranberry juice on vascular function in subjects with coronary artery {disease.{\textless}/AbstractText{\textgreater}} {{\textless}AbstractText} {Label=&quot;RESULTS&quot;} {NlmCategory=&quot;RESULTS&quot;{\textgreater}In} the chronic crossover study, subjects with coronary heart disease consumed a research preparation of double-strength cranberry juice (54% juice, 835 mg total polyphenols, and 94 mg anthocyanins) or a matched placebo beverage (480 {mL/d)} for 4 wk each with a 2-wk rest period between beverages. Beverage order was randomly assigned, and participants refrained from consuming other flavonoid-containing beverages during the study. Vascular function was measured before and after each beverage, with follow-up testing ≥12 h after consumption of the last beverage. Mean {(±SD)} carotid-femoral pulse wave velocity, a measure of central aortic stiffness, decreased after cranberry juice (8.3 ± 2.3 to 7.8 ± 2.2 m/s) in contrast with an increase after placebo (8.0 ± 2.0 to 8.4 ± 2.8 m/s) {(P} = 0.003). Brachial artery flow-mediated dilation, digital pulse amplitude tonometry, blood pressure, and carotid-radial pulse wave velocity did not change. In the uncontrolled pilot study, we observed improved brachial artery flow-mediated dilation (7.7 ± 2.9% to 8.7 ± 3.1%</style></abstract><notes><style face="normal" font="default" size="100%">{PMID:} 21411615</style></notes></record></records></xml>